Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AACR, adult, advisor, Alto, AML, Anderson, Andrew, anemia, Anglia, ASH, Austin, Avenue, azacitidine, Baker, benchmark, Biomedical, Biotech, blinded, burden, CA, Canada, Captisol, carryforward, Chambon, clnical, Contemporaneously, content, convenience, County, CR, CT, CyDex, Dacogen, Dartmouth, DC, decitabine, Delagardelle, deliverable, Devonshire, disability, domestic, East, Edward, elderly, enduring, epithelial, Fairfield, Fidelity, Floor, FMR, Fraser, Gilead, Glover, Graham, Heaton, highlighted, Hunt, hypomethylating, indirect, inefficient, Insider, intangible, IPO, JAK, Jeani, jeopardized, Johnson, Josiah, judicially, Lathi, Leaf, lengthy, lethal, leukemic, LLP, Madison, membership, monoclonal, Niedel, NLV, nontransferable, NY, opportunistic, Palo, Panobinostat, pecuniary, percentile, Philippe, pilot, point, preclinical, promulgated, recordkeeping, RECOTHROM, remission, renamed, reputation, retirement, Ridgefield, Ronald, RSU, Seattle, Simon, site, Somatix, splenomegaly, Squibb, Stanford, surrendered, topline, transformation, underwritten, unexercised, untreated, unvested, venture, VII, Vijay, Viventia, vorinostat, Washington, YM, Zolinza
Removed:
aberrant, acquirer, Adelaide, amounting, analogue, assigned, Australian, blood, borrowing, call, capacity, carcinoma, Centre, collateral, comparison, conflict, consolidation, constantly, contrast, create, cumulative, currency, dacarbazine, debt, decreased, delisted, demand, devoting, direction, discouraged, discouraging, disrupt, distinct, effectively, eventually, excluding, extend, functional, fundamental, Gil, Hanson, harm, harmful, hearing, hedging, hierarchy, Hospital, impeding, inability, indirectly, interaction, intercompany, interpreted, intracellular, killing, living, long, lung, margin, mature, melanoma, merger, Mor, notification, NSCLC, obligated, pancreatic, pressure, priced, proliferative, promote, pursuing, quoted, ratio, rational, reflecting, regain, register, renewal, resistant, revealed, revoked, Royal, royalty, screening, selling, spent, Structurally, takeover, territory, topical, transfer, translated, unregistered, vessel, viability, whichever, xenograft
Filing tables
Filing exhibits
MEIP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
MEI Pharma, Inc.
11975 El Camino Real, Suite 101
San Diego, CA 92130
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (FileNos. 333-186070, 333-184011, 333-174789, 333-173266, 333-146453, and 333-136440) and the Registration Statements on Form S-8 (File Nos. 333-179591, 333-174790, 333-169719, and 333-156985) of MEI Pharma, Inc. (the “Company”) of our report dated September 17, 2013, relating to the financial statements, which appears in the Annual Report on Form 10-K.
/s/ BDO USA, LLP
San Diego, California
September 17, 2013